What an unbelievably beautiful and newly added slide #20 in the most recent OPT presentation (=> click here <=) giving those investors that do not really feel at ease with things kind of „delta“, „p-value“, „standard deviation“ etc. when it comes to clinical trail analysis, an extremely impressive and intuitive way of understanding in what the P2b results of sozinibercept are so particular, remarkable, outstanding and unusually strong.
10/10 points for the person within Opthea that had the idea for this slide. Absolutely great work!
What an unbelievably beautiful and newly added slide #20 in the...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.045(6.43%) |
Mkt cap ! $806.3M | |||
| Open | High | Low | Value | Volume |
| 69.5¢ | 69.5¢ | 63.0¢ | $2.808M | 4.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49996 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 50869 | 6 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |